TGF-β and EGF pathways are involved in the regulation of many cancer-associated signaling pathways, suggesting that in addition to the loss of tight junctions in an OMD−/− or PRELP−/− bladder, further regulation of TGF-β and EGF downstream signaling components might be required for cancer initiation. This evidence concerns the gene PRELP and cancer.